Granahan Investment Management, LLC

Position in TSHA — Taysha Gene Therapies, Inc.

CIK 1026710 WALTHAM, MA

Position in TSHA

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$8,888,255

+$4,940,168 QoQ

Shares Held

1,305,177

+47.8% QoQ

Ownership

0.401%

of shares outstanding

% of Portfolio

0.32%

of 13F equity value

Holder Rank

#41

of 209 holders

Holding Since

Jun 2024

9 quarters on record

Voting authority Sole 90% Shared 0% None 10%

Healthcare · as of Jun 30, 2026

Granahan Investment Management, LLC holds $259,488,707 across 26 Biotechnology names. TSHA ranks #8 (3.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LGND	Ligand Pharmaceuticals Inc	147,231	$46,538,246
2	TWST	Twist Bioscience Corp	314,882	$32,395,060
3	CELC	Celcuity Inc.	179,053	$18,732,524
4	STOK	Stoke Therapeutics, Inc.	461,608	$15,103,813
5	SNDX	Syndax Pharmaceuticals Inc	446,988	$9,771,157
6	RYTM	Rhythm Pharmaceuticals, Inc.	83,270	$9,245,468
7	SRRK	Scholar Rock Holding Corp	163,759	$9,006,745
8	TSHA	Taysha Gene Therapies, Inc. This page	1,305,177	$8,888,255

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$8,888,255	1,305,177	+47.8%	Shares	Sole	2026-08-14
2026-03-31	$3,948,087	883,241	+25.5%	Shares	Sole	2026-05-15
2025-12-31	$3,871,840	703,971	-37.0%	Shares	Sole	2026-02-17
2025-09-30	$3,651,376	1,116,629	+16.5%	Shares	Sole	2025-11-14
2025-06-30	$2,214,118	958,493	-41.6%	Shares	Sole	2025-08-14
2025-03-31	$2,280,702	1,640,793	+0.3%	Shares	Sole	2025-05-15
2024-12-31	$2,830,939	1,636,381	+43.6%	Shares	Sole	2025-02-14
2024-09-30	$2,291,196	1,139,899	+40.8%	Shares	Sole	2024-11-14
2024-06-30	$1,813,707	809,691	—	Shares	Sole	2024-08-14
No filing history on record for this holder in this stock.